142 related articles for article (PubMed ID: 36403273)
41. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.
Thuijs DJFM; Kappetein AP; Serruys PW; Mohr FW; Morice MC; Mack MJ; Holmes DR; Curzen N; Davierwala P; Noack T; Milojevic M; Dawkins KD; da Costa BR; Jüni P; Head SJ;
Lancet; 2019 Oct; 394(10206):1325-1334. PubMed ID: 31488373
[TBL] [Abstract][Full Text] [Related]
42. [Effect of percutaneous coronary intervention and
medical therapy on quality of life and cognitive function in patients with coronary heart disease].
Cao F; Zhang B; Li X; Duan S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):544-551. PubMed ID: 29886471
[TBL] [Abstract][Full Text] [Related]
43. Long-Term Mortality in Patients With Radiation-Associated Coronary Artery Disease Treated With Percutaneous Coronary Intervention.
Reed GW; Masri A; Griffin BP; Kapadia SR; Ellis SG; Desai MY
Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313281
[TBL] [Abstract][Full Text] [Related]
44. Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
Miyoshi T; Ejiri K; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Kawai Y; Sato T; Sato K; Oka T; Takahashi N; Sakuragi S; Mima A; Enko K; Hosogi S; Nanba S; Hirami R; Nakamura K; Ito H;
Int J Cardiol; 2017 Jun; 236():36-42. PubMed ID: 28214082
[TBL] [Abstract][Full Text] [Related]
45. The ReACT Trial: Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial.
Shiomi H; Morimoto T; Kitaguchi S; Nakagawa Y; Ishii K; Haruna Y; Takamisawa I; Motooka M; Nakao K; Matsuda S; Mimoto S; Aoyama Y; Takeda T; Murata K; Akao M; Inada T; Eizawa H; Hyakuna E; Awano K; Shirotani M; Furukawa Y; Kadota K; Miyauchi K; Tanaka M; Noguchi Y; Nakamura S; Yasuda S; Miyazaki S; Daida H; Kimura K; Ikari Y; Hirayama H; Sumiyoshi T; Kimura T;
JACC Cardiovasc Interv; 2017 Jan; 10(2):109-117. PubMed ID: 28040445
[TBL] [Abstract][Full Text] [Related]
46. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of an individualised programme to promote self-care in sleep-activity in patients with coronary artery disease -- a randomised intervention study.
Johansson A; Adamson A; Ejdebäck J; Edéll-Gustafsson U
J Clin Nurs; 2014 Oct; 23(19-20):2822-34. PubMed ID: 24479893
[TBL] [Abstract][Full Text] [Related]
48. The association between self-reported health status and adverse events: a comparison among coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI).
Nielsen SN; Rasmussen TB; Lassen JF; Berg SK; Thrysoee L; Møller JE; Jensen LO; Thuesen AL; Christensen AV; Ekholm O; Mols R; Thorup CB; Borregaard B
Qual Life Res; 2020 Nov; 29(11):3017-3029. PubMed ID: 32857268
[TBL] [Abstract][Full Text] [Related]
49. Fate of Patients With Coronary Perforation Complicating Percutaneous Coronary Intervention (from the Euro Heart Survey Percutaneous Coronary Intervention Registry).
Bauer T; Boeder N; Nef HM; Möllmann H; Hochadel M; Marco J; Weidinger F; Zeymer U; Gitt AK; Hamm CW
Am J Cardiol; 2015 Nov; 116(9):1363-7. PubMed ID: 26341189
[TBL] [Abstract][Full Text] [Related]
50. Influence of hypercholesterolemia and diabetes on long-term outcome in patients with stable coronary artery disease receiving percutaneous coronary intervention.
Lin MJ; Chang YJ; Chen CY; Huang CC; Chuang TY; Wu HP
Medicine (Baltimore); 2019 Aug; 98(34):e16927. PubMed ID: 31441878
[TBL] [Abstract][Full Text] [Related]
51. Myocardial revascularisation in renal dysfunction: a systematic review and meta-analysis.
Deo SV; Shah IK; Dunlay SM; Erwin PJ; Dillon JM; Park SJ
Heart Lung Circ; 2013 Oct; 22(10):827-35. PubMed ID: 23548338
[TBL] [Abstract][Full Text] [Related]
52. Sustained 3-Year Benefits in Quality of Life After Percutaneous Coronary Interventions in the Elderly: A Prospective Cohort Study.
Yan BP; Chan LLY; Lee VWY; Yu CM; Wong MCS; Sanderson J; Reid CM
Value Health; 2018 Apr; 21(4):423-431. PubMed ID: 29680099
[TBL] [Abstract][Full Text] [Related]
53. Impacts of Omaha System-Based Continuing Care on the Medication Compliance, Quality of Life, and Prognosis of Coronary Heart Disease Patients After PCI.
Yin S; Ou Y; Ting E
Braz J Cardiovasc Surg; 2022 Aug; 37(4):472-480. PubMed ID: 35976205
[TBL] [Abstract][Full Text] [Related]
54. The Current State of Left Main Percutaneous Coronary Intervention.
Avula HR; Rassi AN
Curr Atheroscler Rep; 2018 Jan; 20(1):3. PubMed ID: 29344756
[TBL] [Abstract][Full Text] [Related]
55. Meta-analysis study comparing percutaneous coronary intervention/drug eluting stent versus coronary artery bypass surgery of unprotected left main coronary artery disease: Clinical outcomes during short-term versus long-term (> 1 year) follow-up.
Ali WE; Vaidya SR; Ejeh SU; Okoroafor KU
Medicine (Baltimore); 2018 Feb; 97(7):e9909. PubMed ID: 29443766
[TBL] [Abstract][Full Text] [Related]
56. Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease.
Kolkailah AA; Alreshq RS; Muhammed AM; Zahran ME; Anas El-Wegoud M; Nabhan AF
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD012318. PubMed ID: 29665617
[TBL] [Abstract][Full Text] [Related]
57. An Australian longitudinal pilot study examining health determinants of cardiac outcomes 12 months post percutaneous coronary intervention.
Edward KL; Stephenson J; Giandinoto JA; Wilson A; Whitbourn R; Gutman J; Newcomb A
BMC Cardiovasc Disord; 2016 Feb; 16():31. PubMed ID: 26841927
[TBL] [Abstract][Full Text] [Related]
58. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with coronary heart disease and type 2 diabetes mellitus: Cumulative meta-analysis.
Xie Q; Huang J; Zhu K; Chen Q
Clin Cardiol; 2021 Jul; 44(7):899-906. PubMed ID: 34089266
[TBL] [Abstract][Full Text] [Related]
59. Social and Economic Costs and Health-Related Quality of Life in Patients With Acute Coronary Syndrome.
Sheikhgholami S; Ebadifardazar F; Rezapoor A; Tajdini M; Salarifar M
Value Health Reg Issues; 2021 May; 24():123-129. PubMed ID: 33571726
[TBL] [Abstract][Full Text] [Related]
60. Preliminary report on a cost-utility analysis of revascularization by percutaneous coronary intervention for ischemic heart disease.
Takura T; Tachibana K; Isshiki T; Sumitsuji S; Kuroda T; Mizote I; Ide S; Nanto S
Cardiovasc Interv Ther; 2017 Apr; 32(2):127-136. PubMed ID: 27230087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
